CBDG (THC Farmaceuticals) Loans Receivable: $0.62 Mil (As of Jun. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Farmaceuticals Loans Receivable?

THC Farmaceuticals CBDG -74.29% Loans Receivable is $0.62 Mil as of Jun. 2018.

THC Farmaceuticals's Loans Receivable for the quarter that ended in Jun. 2018 was $0.62 Mil.

THC Farmaceuticals's quarterly Loans Receivable increased from Jun. 2017 ($0.00 Mil) to Mar. 2018 ($0.62 Mil) but then stayed the same from Mar. 2018 ($0.62 Mil) to Jun. 2018 ($0.62 Mil).

THC Farmaceuticals Loans Receivable Related Terms

THC Farmaceuticals Loans Receivable Historical Data

* Premium members only.

The historical data trend for THC Farmaceuticals's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Farmaceuticals Loans Receivable Chart

THC Farmaceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13
Loans Receivable
0.00 0.00 0.00 0.00

THC Farmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Mar17 Jun17 Mar18 Jun18
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.62 0.62

THC Farmaceuticals Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of $0.62 Mil mean?
THC Farmaceuticals (CBDG) has a Loans Receivable of $0.62 Mil as of Jun. 2018. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on THC Farmaceuticals and its competitors.
Is THC Farmaceuticals' Loans Receivable too high?
THC Farmaceuticals' current Loans Receivable is $0.62 Mil.
How does THC Farmaceuticals' Loans Receivable compare to BOXS?
THC Farmaceuticals' Loans Receivable of $0.62 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Biotechnology company?
A good Loans Receivable depends on the Biotechnology industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on THC Farmaceuticals and its competitors. THC Farmaceuticals's current Loans Receivable is $0.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THC Farmaceuticals stock overvalued right now?
THC Farmaceuticals (CBDG) has a current Loans Receivable of $0.62 Mil. The current Loans Receivable is $0.62 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For THC Farmaceuticals (CBDG), the current Loans Receivable is $0.62 Mil as of Jun. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THC Farmaceuticals Business Description

Address 2789 Rio Vista Drive, Suite 3, Saint George, UT, USA, 84790
THC Farmaceuticals Inc is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel cannabinoid-based products in dental, ophthalmology, and other medical disciplines. It offers the combination of proprietary developments with the expertise of clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds.